4:26 PM ET
8-K
Leadership Change
Lisata Therapeutics Leadership Change
Lisata Therapeutics appointed Jeffrey Farrow to its Board of Directors as a Class III member and a member of the Audit Committee, effective October 13, 2026. The appointment expands the company's board from seven to eight members. Mr. Farrow is a veteran biopharmaceutical executive currently serving as CFO and Chief Strategy Officer of Tarsus Pharmaceuticals.